First Human Trial Of Experimental Zika Vaccine To Begin In U.S. Soon

CNN: First Zika vaccine to be tested in humans
“The first human trial of a Zika vaccine will begin soon, Inovio Pharmaceuticals said Monday. Inovio, which is based in Plymouth Meeting, Pennsylvania, and GeneOne Life Science, which is based in Seoul, South Korea, worked together on the vaccine…” (Christensen, 6/20).

The Guardian: Human testing of experimental Zika vaccine to begin
“Scientists expect to test the first experimental Zika vaccine on humans in the coming weeks, after the pharmaceutical company Inovio received approval from the U.S. Food and Drug Administration to start a small clinical trial…” (Glenza, 6/20).

The Hill: Zika vaccine approved for first human testing
“…Funding for vaccine research is one of the aspects of the $1.9 billion the White House requested to Congress…” (Sullivan, 6/20).

STAT: Experimental Zika vaccine is approved for clinical trials for first time in U.S.
“…Interim results from the trial, which will involve 40 healthy adults, are expected later this year. Testing in mice and monkeys has shown the vaccine triggered what Inovio called a robust antibody response…” (Branswell, 6/20).

Washington Post: Scientists announce important Zika milestone: First vaccine ready for human trials
“…Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, has said he believes the world’s best hope against Zika is a vaccine and that, because of previous research on West Nile and dengue, a Zika vaccine should take less time to develop than vaccines for many other infectious diseases…” (Cha, 6/20).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.